Prescription digital therapeutics in obesity management: Present and future

Prescription digital therapeutics (PDTs) are emerging as innovative solutions in the management of obesity, complementing traditional methods such as lifestyle interventions, pharmacotherapy, and surgery. This mini-review explores the current landscape and future potential of PDTs in obesity management. We begin by defining PDTs and examining key players and products in the market. These products exemplify the integration of artificial intelligence -driven personalized coaching and real-time data tracking to enhance user engagement and treatment efficacy. Clinical evidence supporting the effectiveness of PDTs in promoting weight loss and improving metabolic health is discussed, with an emphasis on the comparative studies with traditional interventions. The review also addresses challenges such as regulatory hurdles, user adherence, data privacy, and accessibility issues. Looking forward, advancements in technology, personalized medicine, and better integration with healthcare systems are poised to further enhance the impact of PDTs. This article underscores the potential of PDTs to revolutionize obesity management and calls for continued innovation and research in this field.